VC  Lightstone Ventures

http://lightstonevc.com





     Office Locations:

2884 Sand Hill Road, Suite 121
Menlo Park, CA 94025
Phone: 650-388-3676
Fax: 650-388-3675

Get all office locations for this firm with a National Database subscription or Silicon Valley Database subscription.
 

Stages:

  • Early
  • Expansion
  • Growth


 

Industries:

  • Life Sciences & Healthcare
  • Medical Device

  •  

    Description:

    Lightstone Ventures was founded in 2012 by the General Partners and other key members of the life science teams of Advanced Technology Ventures (ATV) and Morgenthaler. The firm was formed to capture the upside of investing in breakthrough life science companies during a time of unique opportunity in the space. Members of the Lightstone team have worked together on numerous new life science enterprises over the last decade. Members of the Lightstone team manage a portfolio of more than 50 medical device and biotechnology companies across the ATV and Morgenthaler legacy funds (Legacy Funds). Lightstone invests in early stage therapeutics, with later stage investments pursued selectively. The firm pursues a balance between investing in breakthrough medical device and novel biopharmaceutical companies that have the potential to change medicine.


     

    Funds:


      Fund Name


      Amount


      Date

    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription or Silicon Valley Database subscription.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or Silicon Valley Database subscription.
    Alain Baron M.D. Venture Partner
    Anna Turetsky Ph.D. Vice President
    Caroline Gaynor Vice President
    Chris Christoffersen Ph.D. General Partner
    Hank Plain General Partner

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      06/05/2018


      Nimbus Therapeutics


      MA


      $65,000,000


      Venture


      03/08/2018


      Cyteir Therapeutics


      MA


      $29,000,000


      Series B


      10/17/2017


      Gemini Therapeutics


      MA


      $42,500,000


      Series A


     

    Portfolio companies include:


      Acceleron
        web link


      Altura Medical
        web link


      Cabochon
        web link


      Calithera
        web link


      Catabasis
        web link


      Catalyst Biosciences
        web link


      Claret Medical
        web link


      Cyteir Therapeutics
        web link


      EarLens
        web link


      EndoGastric Solutions
        web link


      FIRE1
        web link


      FivePrime
        web link


      Flex Pharma
        web link


      Galleon
        web link


      Gemini Therapeutics
        web link


      GlobeImmune
        web link


      Holaira
        web link


      Hydra Biosciences
        web link


      Kona Medical
        web link


      Miramar Labs
        web link


      Mosiac Biosciences
        web link


      Moximed
        web link


      NaZura BioHealth
        web link


      Nexis Vision
        web link


      Nimbus Therapeutics
        web link


      OncoMed
        web link


      Portola
        web link


      Principia
        web link


      Promedior
        web link


      Ra Pharma
        web link


      Scioderm
        web link


      Second Genome
        web link


      SetPoint Medical
        web link


      Spine Wave
        web link


      Stemgent
        web link


      Thrasos Therapeutics
        web link


      Tizona Therapeutics
        web link


      Tragara
        web link


      Transcend Medical
        web link


      Twelve


      Vapotherm
        web link


     

    Recent News:


      There is no recent news for Lightstone Ventures.